Company profile for Nexel

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

NEXEL is a global leader in iPSC (induced pluripotent stem cell) technology, and the first Korean company to license iPS tech. We pioneer in vitro toxicity testing using iPS-derived cells that closely replicate human biology. Our mission to ?Make a Better Place? drives us to develop protein- and peptide-based therapies from stem cell innovations, supporting patients and empowering researchers. Backed by a passionate team and s...
NEXEL is a global leader in iPSC (induced pluripotent stem cell) technology, and the first Korean company to license iPS tech. We pioneer in vitro toxicity testing using iPS-derived cells that closely replicate human biology. Our mission to ?Make a Better Place? drives us to develop protein- and peptide-based therapies from stem cell innovations, supporting patients and empowering researchers. Backed by a passionate team and strong academic partnerships, NEXEL is committed to advancing biotech innovation and delivering meaningful value to science and society.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
South Korea
Address
Address
8F, 55 Magokdong-ro, Gangseo-gu, Seoul
Telephone
Telephone
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

AMWC Asia-TDAC

AMWC Asia-TDAC

Not Confirmed

envelop Contact Supplier

AMWC Asia-TDAC

Post an Enquiry

Meeting

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty